Examinant per Autoria "Alba, Emilio"
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert A PAM50-based chemoendocrine score for hormone receptor-positive breast cancer with an intermediate risk of relapse(American Association for Cancer Research (AACR), 2017) Prat, Aleix; Alba, Emilio; Albanell Mestres, Joan
Ítem Accés Obert Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its approval(Impact Journals, 2019) Ciruelos, Eva; Alba, Emilio; López, Rafael; Lluch, Ana; Martín, Miguel; Arroyo, Isabel; Navarro, Beatriz; Carcedo, David; Colomer, Ramon; Albanell Mestres, Joan
Ítem Accés Obert Dual neoadjuvant blockade plus chemotherapy versus monotherapy for the treatment of women with non-metastatic HER2-positive breast cancer: a systematic review and meta-analysis(Springer, 2022) Vazquez, Juan Carlos; Antolin, Silvia; Ruiz-Borrego, Manuel; Servitja Tormo, Sonia; Alba, Emilio; Barnadas, Agustí; Lluch, Ana; Martín, Miguel; Rodríguez-Lescure, Álvaro; Solà, Ivan; Bonfill, Xavier; Urrutia, Gerard; Sanchez-Rovira, Pedro
Ítem Accés Obert NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer(BioMed Central, 2024) Santana-Hernández, Sara; Suárez Olmos, Jesús; Servitja Tormo, Sonia; Berenguer-Molins, Pau; Costa García, Marcel, 1989-; Comerma Blesa, Laura, 1983-; Rea, Anna; Perera Bel, Júlia; Menendez Romero, Silvia; Arpí Llucià, Oriol; Bermejo, Begoña; Martínez, María Teresa; Cejalvo, Juan Miguel; Comino-Méndez, Iñaki; Pascual, Javier; Alba, Emilio; López-Botet, M. (Miguel); Rojo, Federico; Rovira, Ana; Albanell Mestres, Joan; Muntasell i Castellví, Aura, 1972-
Ítem Accés Obert Predicting response and survival in chemotherapy-treated triple-negative breast cancer(Springer, 2014) Prat, Aleix; Alba, Emilio; Albanell Mestres, Joan
Ítem Accés Obert Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial(Nature Research, 2014) Alba, Emilio; Albanell Mestres, Joan; Haba Rodríguez, Juan de la; Barnadas, Agustí; Calvo, Lourdes; Sánchez-Rovira, Pedro; Ramos, Manuel; Rojo, Federico; Burgués, Octavio; Carrasco, Eva María; Caballero, Rosalía; Porras, Ignacio; Tibau, Ariadna; Cámara, Maria del Carmen; Lluch, Ana
Ítem Accés Obert Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy(Impact Journal, 2018) Santonja, Angela; Albanell Mestres, Joan; Alba, Emilio